• 1
    Battle SE, Rello J, Hauser AR. Genomic Islands in Pseudomonas aeruginosa. FEMS Microbiol Lett 2009; 290: 7078.
  • 2
    Hacker J, Carniel E. Ecological fitness, genomic islands and bacterial pathogenicity: a Darwinian view of the evolution of microbes. EMBO Rep 2001; 2: 376381.
  • 3
    Kung VL, Ozer EA, Hauser AR. The acessory genome of Pseudomonas aeruginosa. Microbiol Mol Bio Rev 2010; 74: 621641.
  • 4
    Vinogradova Y, Hippisley-Cox J, Coupland C. Identification of new risk factors for pneumonia: population-based case-control study. Br J Gen Pract 2009; 59: e329e338.
  • 5
    European Parliament and Council. Directive 2009/54/EC of European Parliament and of the Council of 18 June 2009 on the exploitation and marketing of natural mineral waters. Official J Eur Union 2009; L164: 4558.
  • 6
    Rosser SJ, Young H-K. Identification and characterization of class 1 integrons in bacteria from an aquatic environment. J Antimicrob Chemother 1999; 44: 1118.
  • 7
    Klockgether J, Wüdermann D, Reva O, Wielhmann L, Tümmler B. Diversity of the abundant pKLC102/PAGI-2 family of genomic islands in Pseudomonas aeruginosa. J Bacteriol 2007; 189: 24432459.
  • 8
    Ruiz-Martínez L, López-Jiménez L, Fusté E, Vinuest T, Martínez JL, Viñas M. Class 1 integrons in environmental and clinical isolates of Pseudomonas aeruginosa. Int J Antmicrob Agents 2011; 38: 398402.
  • 9
    Zanetti MO, Martins W, Pitondo-Silva A, Stehling EG. Antimicrobial resistance, plasmids and class 1 and 2 integrons occurring in Pseudomonas aeruginosa isolated from Brazilian aquatic environments. Water Sci Technol 2013; 67: 11441149.
  • 10
    Crosa JH, Tolmasky ME, Actis LA, Falkow S. Plasmids. In: Gerhardt P, Murray RGE, Wood WA, Kreig NR, eds, Methods for general and molecular microbiology. Washington, USA: American Society for Microbiology, 1994; 365386.
  • 11
    Barton BM, Harding GP, Zuccarelli AJ. A general method for detecting and sizing large plasmids. Anal Biochem 1995; 226: 235240.
  • 12
    Mazel D, Dychinco B, Webb VA, Davies J. Antibiotic resistance in the ECOR collection: integrons and identification of a novel aad gene. Antimicrob Agents Chemother 2000; 44: 1581574.
  • 13
    Cardoso O, Alves AF, Leitão R. Metallo-beta-lactamase VIM-2 Pseudomonas aeruginosa isolates from a cystic fibrosis patient. Int J Antimicrob Agents 2008; 31: 375379.
  • 14
    Finnan S, Morrissey JP, O'Gara F, Boyd EF. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment. J Clin Microbiol 2004; 42: 57835792.
  • 15
    Kristiansson E, Fick J, Janzon A et al. Pyrosequencing of antibiotic-contaminated river sediments reveals high levels of resistance and gene transfer elements. PLoS One 2007; 6: e17038.
  • 16
    Morales-Espinosa R, Soberón-Chávez G, Delgado-Sapién G et al. Genetic and phenotypic characterization of a Pseudomonas aeruginosa population with high frequency of genomic islands. PLoS One 2012; 7: e37459.
  • 17
    Engel J, Balachandran P. Role of Pseudomonas aeruginosa type III effectors in disease. Cur Opin Microbiol 2009; 12: 6166.
  • 18
    Hauser AR. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol 2009; 7: 654665.